Massachusetts Financial Services’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
311,455
+3,848
| +1% | +$14.5K | ﹤0.01% | 801 |
|
|
2025
Q1 | $1.39M | Sell |
307,607
-7,008
| -2% | -$31.7K | ﹤0.01% | 787 |
|
|
2024
Q4 | $2.22M | Sell |
314,615
-9,387
| -3% | -$66.4K | ﹤0.01% | 750 |
|
|
2024
Q3 | $2.64M | Sell |
324,002
-7,845
| -2% | -$63.9K | ﹤0.01% | 708 |
|
|
2024
Q2 | $2.12M | Buy |
331,847
+50,297
| +18% | +$321K | ﹤0.01% | 741 |
|
|
2024
Q1 | $2.12M | Buy |
281,550
+28,182
| +11% | +$212K | ﹤0.01% | 728 |
|
|
2023
Q4 | $2.35M | Buy |
253,368
+206,184
| +437% | +$1.91M | ﹤0.01% | 714 |
|
|
2023
Q3 | $478K | Sell |
47,184
-1,809
| -4% | -$18.3K | ﹤0.01% | 805 |
|
|
2023
Q2 | $612K | Sell |
48,993
-1,154
| -2% | -$14.4K | ﹤0.01% | 778 |
|
|
2023
Q1 | $585K | Sell |
50,147
-50,545
| -50% | -$590K | ﹤0.01% | 800 |
|
|
2022
Q4 | $1.07M | Buy |
100,692
+2,132
| +2% | +$22.7K | ﹤0.01% | 770 |
|
|
2022
Q3 | $956K | Buy |
+98,560
| New | +$956K | ﹤0.01% | 783 |
|
|
2021
Q4 | – | Sell |
-22,101
| Closed | -$1.11M | – | 910 |
|
|
2021
Q3 | $1.11M | Sell |
22,101
-325,395
| -94% | -$16.3M | ﹤0.01% | 826 |
|
|
2021
Q2 | $19.3M | Sell |
347,496
-986
| -0.3% | -$54.7K | 0.01% | 619 |
|
|
2021
Q1 | $16.3M | Sell |
348,482
-153,246
| -31% | -$7.17M | 0.01% | 627 |
|
|
2020
Q4 | $21.8M | Sell |
501,728
-187,115
| -27% | -$8.15M | 0.01% | 583 |
|
|
2020
Q3 | $25.2M | Sell |
688,843
-123,883
| -15% | -$4.53M | 0.01% | 540 |
|
|
2020
Q2 | $23.7M | Buy |
+812,726
| New | +$23.7M | 0.01% | 528 |
|